Search results

1. Is this the end for MacroGenics’ vobra-duo?

   … Ph2 Tamarack trial discontinued Jul 2024; more data due at ESMO 2024 Lorigerlimab Anti-PD-1 x CTLA-4 …

   
    

   Madeleine Armstrong
    
   - 08/05/2024 - 12:30

2. ESMO 2024 preview – Summit and BioNTech battle again

   ESMO 2024 preview – Summit and BioNTech battle again … NGM707 (which also hits ILT4).   Selected ESMO 2024 oral presentations featuring biologicals …

   
    

   Madeleine Armstrong
    
   - 07/24/2024 - 10:26

3. ESMO 2024 preview – Astellas unveils its KRAS degrader

   ESMO 2024 preview – Astellas unveils its KRAS degrader … straight SMARCA2 inhibitor FHD-909 .   Selected ESMO 2024 oral presentations on small-molecule approaches …

   
    

   Jacob Plieth
    
   - 07/24/2024 - 17:44

4. ESMO 2024 preview – conjugates in the spotlight

   ESMO 2024 preview – conjugates in the spotlight … hasn't yet yielded any clinical data.   Selected ESMO 2024 oral presentations featuring ADCs …

   
    

   Jacob Plieth
    
   - 07/23/2024 - 13:17